nodes	percent_of_prediction	percent_of_DWPC	metapath
Nevirapine—CYP2A6—Fluorouracil—head and neck cancer	0.217	0.28	CbGbCtD
Nevirapine—CYP2D6—Hydroxyurea—head and neck cancer	0.178	0.231	CbGbCtD
Nevirapine—CYP3A5—Docetaxel—head and neck cancer	0.0849	0.11	CbGbCtD
Nevirapine—CYP1A2—Fluorouracil—head and neck cancer	0.0828	0.107	CbGbCtD
Nevirapine—CYP2C9—Fluorouracil—head and neck cancer	0.0746	0.0963	CbGbCtD
Nevirapine—CYP2D6—Vinblastine—head and neck cancer	0.0632	0.0816	CbGbCtD
Nevirapine—CYP3A4—Vinblastine—head and neck cancer	0.0402	0.0519	CbGbCtD
Nevirapine—CYP3A4—Docetaxel—head and neck cancer	0.0331	0.0428	CbGbCtD
Nevirapine—Developmental delay—Fluorouracil—head and neck cancer	0.00566	0.0311	CcSEcCtD
Nevirapine—Congenital anomaly—Fluorouracil—head and neck cancer	0.00566	0.0311	CcSEcCtD
Nevirapine—Blister—Hydroxyurea—head and neck cancer	0.00415	0.0228	CcSEcCtD
Nevirapine—Bullous eruption—Docetaxel—head and neck cancer	0.00393	0.0216	CcSEcCtD
Nevirapine—Hepatotoxicity—Hydroxyurea—head and neck cancer	0.00387	0.0213	CcSEcCtD
Nevirapine—Hepatic enzyme increased—Hydroxyurea—head and neck cancer	0.00316	0.0174	CcSEcCtD
Nevirapine—Ulcer—Hydroxyurea—head and neck cancer	0.00316	0.0174	CcSEcCtD
Nevirapine—Blister—Fluorouracil—head and neck cancer	0.00299	0.0164	CcSEcCtD
Nevirapine—Skin exfoliation—Hydroxyurea—head and neck cancer	0.00285	0.0157	CcSEcCtD
Nevirapine—Necrosis—Fluorouracil—head and neck cancer	0.00274	0.0151	CcSEcCtD
Nevirapine—Foetor hepaticus—Docetaxel—head and neck cancer	0.00274	0.015	CcSEcCtD
Nevirapine—Rash maculo-papular—Hydroxyurea—head and neck cancer	0.00272	0.0149	CcSEcCtD
Nevirapine—Hepatic failure—Hydroxyurea—head and neck cancer	0.00242	0.0133	CcSEcCtD
Nevirapine—Liver disorder—Docetaxel—head and neck cancer	0.00228	0.0125	CcSEcCtD
Nevirapine—Ulcer—Fluorouracil—head and neck cancer	0.00228	0.0125	CcSEcCtD
Nevirapine—CYP1A2—Arylamine metabolism—NAT2—head and neck cancer	0.00228	0.0518	CbGpPWpGaD
Nevirapine—Dermatitis bullous—Hydroxyurea—head and neck cancer	0.00227	0.0125	CcSEcCtD
Nevirapine—Inflammation—Fluorouracil—head and neck cancer	0.00222	0.0122	CcSEcCtD
Nevirapine—Face oedema—Hydroxyurea—head and neck cancer	0.0021	0.0115	CcSEcCtD
Nevirapine—Rash erythematous—Docetaxel—head and neck cancer	0.00203	0.0111	CcSEcCtD
Nevirapine—Hepatotoxicity—Docetaxel—head and neck cancer	0.00201	0.0111	CcSEcCtD
Nevirapine—Necrosis—Docetaxel—head and neck cancer	0.00198	0.0109	CcSEcCtD
Nevirapine—Rash maculo-papular—Fluorouracil—head and neck cancer	0.00196	0.0107	CcSEcCtD
Nevirapine—Pancreatitis—Hydroxyurea—head and neck cancer	0.00184	0.0101	CcSEcCtD
Nevirapine—Neuropathy peripheral—Vinblastine—head and neck cancer	0.0018	0.00988	CcSEcCtD
Nevirapine—Neutropenia—Hydroxyurea—head and neck cancer	0.00175	0.00964	CcSEcCtD
Nevirapine—Bone disorder—Docetaxel—head and neck cancer	0.00172	0.00945	CcSEcCtD
Nevirapine—Agranulocytosis—Vinblastine—head and neck cancer	0.00171	0.0094	CcSEcCtD
Nevirapine—Drug interaction—Docetaxel—head and neck cancer	0.00167	0.0092	CcSEcCtD
Nevirapine—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00164	0.00901	CcSEcCtD
Nevirapine—Dermatitis bullous—Fluorouracil—head and neck cancer	0.00163	0.00898	CcSEcCtD
Nevirapine—CYP2A6—Fluoropyrimidine Activity—XRCC3—head and neck cancer	0.00162	0.0368	CbGpPWpGaD
Nevirapine—Inflammation—Docetaxel—head and neck cancer	0.0016	0.0088	CcSEcCtD
Nevirapine—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00158	0.00869	CcSEcCtD
Nevirapine—Blood pressure increased—Docetaxel—head and neck cancer	0.00155	0.00854	CcSEcCtD
Nevirapine—Hepatocellular injury—Docetaxel—head and neck cancer	0.00155	0.00854	CcSEcCtD
Nevirapine—Skin exfoliation—Docetaxel—head and neck cancer	0.00148	0.00815	CcSEcCtD
Nevirapine—Eosinophilia—Fluorouracil—head and neck cancer	0.00134	0.00735	CcSEcCtD
Nevirapine—Ill-defined disorder—Vinblastine—head and neck cancer	0.00133	0.00731	CcSEcCtD
Nevirapine—Anaemia—Vinblastine—head and neck cancer	0.00132	0.00728	CcSEcCtD
Nevirapine—Erythema—Hydroxyurea—head and neck cancer	0.00131	0.00718	CcSEcCtD
Nevirapine—Malaise—Vinblastine—head and neck cancer	0.00129	0.0071	CcSEcCtD
Nevirapine—Hepatic failure—Docetaxel—head and neck cancer	0.00125	0.00689	CcSEcCtD
Nevirapine—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00121	0.00666	CcSEcCtD
Nevirapine—Anaemia—Hydroxyurea—head and neck cancer	0.00121	0.00664	CcSEcCtD
Nevirapine—Discomfort—Vinblastine—head and neck cancer	0.00121	0.00662	CcSEcCtD
Nevirapine—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00118	0.00648	CcSEcCtD
Nevirapine—Dermatitis bullous—Docetaxel—head and neck cancer	0.00118	0.00648	CcSEcCtD
Nevirapine—Malaise—Hydroxyurea—head and neck cancer	0.00118	0.00648	CcSEcCtD
Nevirapine—Conjunctivitis—Fluorouracil—head and neck cancer	0.00117	0.00643	CcSEcCtD
Nevirapine—Thrombocytopenia—Vinblastine—head and neck cancer	0.00115	0.00629	CcSEcCtD
Nevirapine—Agranulocytosis—Fluorouracil—head and neck cancer	0.00112	0.00617	CcSEcCtD
Nevirapine—Anorexia—Vinblastine—head and neck cancer	0.00112	0.00613	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00111	0.00607	CcSEcCtD
Nevirapine—Discomfort—Hydroxyurea—head and neck cancer	0.0011	0.00604	CcSEcCtD
Nevirapine—CYP2A6—Fluoropyrimidine Activity—DPYD—head and neck cancer	0.00107	0.0244	CbGpPWpGaD
Nevirapine—Oedema—Hydroxyurea—head and neck cancer	0.00107	0.00586	CcSEcCtD
Nevirapine—Paraesthesia—Vinblastine—head and neck cancer	0.00105	0.00577	CcSEcCtD
Nevirapine—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00105	0.00575	CcSEcCtD
Nevirapine—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00104	0.00574	CcSEcCtD
Nevirapine—Liver function test abnormal—Docetaxel—head and neck cancer	0.00104	0.00572	CcSEcCtD
Nevirapine—Skin disorder—Hydroxyurea—head and neck cancer	0.00104	0.00569	CcSEcCtD
Nevirapine—CYP2A6—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.00102	0.0233	CbGpPWpGaD
Nevirapine—Anorexia—Hydroxyurea—head and neck cancer	0.00102	0.00559	CcSEcCtD
Nevirapine—Decreased appetite—Vinblastine—head and neck cancer	0.00102	0.00559	CcSEcCtD
Nevirapine—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.00102	0.00558	CcSEcCtD
Nevirapine—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.00102	0.00558	CcSEcCtD
Nevirapine—Pain—Vinblastine—head and neck cancer	0.001	0.0055	CcSEcCtD
Nevirapine—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.000995	0.00546	CcSEcCtD
Nevirapine—CYP1A2—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.000993	0.0226	CbGpPWpGaD
Nevirapine—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.00099	0.0225	CbGpPWpGaD
Nevirapine—Feeling abnormal—Vinblastine—head and neck cancer	0.000964	0.0053	CcSEcCtD
Nevirapine—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000957	0.00526	CcSEcCtD
Nevirapine—Somnolence—Hydroxyurea—head and neck cancer	0.000948	0.00521	CcSEcCtD
Nevirapine—Erythema—Fluorouracil—head and neck cancer	0.000941	0.00517	CcSEcCtD
Nevirapine—Decreased appetite—Hydroxyurea—head and neck cancer	0.000927	0.0051	CcSEcCtD
Nevirapine—Abdominal pain—Vinblastine—head and neck cancer	0.000925	0.00508	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000921	0.00506	CcSEcCtD
Nevirapine—Fatigue—Hydroxyurea—head and neck cancer	0.00092	0.00505	CcSEcCtD
Nevirapine—Pain—Hydroxyurea—head and neck cancer	0.000912	0.00501	CcSEcCtD
Nevirapine—Neutropenia—Docetaxel—head and neck cancer	0.000911	0.00501	CcSEcCtD
Nevirapine—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.000901	0.0205	CbGpPWpGaD
Nevirapine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000882	0.0201	CbGpPWpGaD
Nevirapine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000879	0.00483	CcSEcCtD
Nevirapine—Anaemia—Fluorouracil—head and neck cancer	0.00087	0.00478	CcSEcCtD
Nevirapine—Hypersensitivity—Vinblastine—head and neck cancer	0.000862	0.00474	CcSEcCtD
Nevirapine—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000862	0.00473	CcSEcCtD
Nevirapine—CYP2A6—Xenobiotics—CYP1A1—head and neck cancer	0.000856	0.0195	CbGpPWpGaD
Nevirapine—Renal failure—Docetaxel—head and neck cancer	0.000854	0.00469	CcSEcCtD
Nevirapine—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000852	0.00468	CcSEcCtD
Nevirapine—Jaundice—Docetaxel—head and neck cancer	0.000847	0.00465	CcSEcCtD
Nevirapine—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.000846	0.0193	CbGpPWpGaD
Nevirapine—Conjunctivitis—Docetaxel—head and neck cancer	0.000845	0.00464	CcSEcCtD
Nevirapine—Body temperature increased—Hydroxyurea—head and neck cancer	0.000843	0.00463	CcSEcCtD
Nevirapine—Asthenia—Vinblastine—head and neck cancer	0.000839	0.00461	CcSEcCtD
Nevirapine—CYP2A6—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000823	0.0187	CbGpPWpGaD
Nevirapine—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000822	0.00452	CcSEcCtD
Nevirapine—Agranulocytosis—Docetaxel—head and neck cancer	0.000811	0.00446	CcSEcCtD
Nevirapine—Myalgia—Fluorouracil—head and neck cancer	0.000801	0.0044	CcSEcCtD
Nevirapine—Diarrhoea—Vinblastine—head and neck cancer	0.0008	0.0044	CcSEcCtD
Nevirapine—Discomfort—Fluorouracil—head and neck cancer	0.000791	0.00435	CcSEcCtD
Nevirapine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000786	0.00432	CcSEcCtD
Nevirapine—Hepatitis—Docetaxel—head and neck cancer	0.00078	0.00429	CcSEcCtD
Nevirapine—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.00077	0.0175	CbGpPWpGaD
Nevirapine—Oedema—Fluorouracil—head and neck cancer	0.000768	0.00422	CcSEcCtD
Nevirapine—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000768	0.00422	CcSEcCtD
Nevirapine—Connective tissue disorder—Docetaxel—head and neck cancer	0.000767	0.00421	CcSEcCtD
Nevirapine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.000767	0.0174	CbGpPWpGaD
Nevirapine—Asthenia—Hydroxyurea—head and neck cancer	0.000765	0.00421	CcSEcCtD
Nevirapine—CYP2A6—Fluoropyrimidine Activity—SMUG1—head and neck cancer	0.000764	0.0174	CbGpPWpGaD
Nevirapine—Nervous system disorder—Fluorouracil—head and neck cancer	0.000753	0.00414	CcSEcCtD
Nevirapine—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000752	0.00413	CcSEcCtD
Nevirapine—Vomiting—Vinblastine—head and neck cancer	0.000744	0.00409	CcSEcCtD
Nevirapine—Erythema multiforme—Docetaxel—head and neck cancer	0.000738	0.00405	CcSEcCtD
Nevirapine—Headache—Vinblastine—head and neck cancer	0.000733	0.00403	CcSEcCtD
Nevirapine—Anorexia—Fluorouracil—head and neck cancer	0.000732	0.00402	CcSEcCtD
Nevirapine—Diarrhoea—Hydroxyurea—head and neck cancer	0.00073	0.00401	CcSEcCtD
Nevirapine—Immune system disorder—Docetaxel—head and neck cancer	0.000705	0.00387	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.0007	0.00384	CcSEcCtD
Nevirapine—Nausea—Vinblastine—head and neck cancer	0.000695	0.00382	CcSEcCtD
Nevirapine—CYP2B6—Xenobiotics—CYP1A1—head and neck cancer	0.000691	0.0157	CbGpPWpGaD
Nevirapine—Paraesthesia—Fluorouracil—head and neck cancer	0.00069	0.00379	CcSEcCtD
Nevirapine—Somnolence—Fluorouracil—head and neck cancer	0.000683	0.00375	CcSEcCtD
Nevirapine—Erythema—Docetaxel—head and neck cancer	0.000679	0.00373	CcSEcCtD
Nevirapine—Vomiting—Hydroxyurea—head and neck cancer	0.000678	0.00373	CcSEcCtD
Nevirapine—CYP3A5—Xenobiotics—CYP1A1—head and neck cancer	0.000675	0.0154	CbGpPWpGaD
Nevirapine—Rash—Hydroxyurea—head and neck cancer	0.000673	0.0037	CcSEcCtD
Nevirapine—Dermatitis—Hydroxyurea—head and neck cancer	0.000672	0.00369	CcSEcCtD
Nevirapine—Headache—Hydroxyurea—head and neck cancer	0.000668	0.00367	CcSEcCtD
Nevirapine—Decreased appetite—Fluorouracil—head and neck cancer	0.000668	0.00367	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000663	0.00364	CcSEcCtD
Nevirapine—Pain—Fluorouracil—head and neck cancer	0.000657	0.00361	CcSEcCtD
Nevirapine—CYP3A5—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000649	0.0148	CbGpPWpGaD
Nevirapine—Nausea—Hydroxyurea—head and neck cancer	0.000634	0.00348	CcSEcCtD
Nevirapine—Feeling abnormal—Fluorouracil—head and neck cancer	0.000633	0.00348	CcSEcCtD
Nevirapine—Anaemia—Docetaxel—head and neck cancer	0.000628	0.00345	CcSEcCtD
Nevirapine—CYP2A6—Fluoropyrimidine Activity—TYMS—head and neck cancer	0.000612	0.0139	CbGpPWpGaD
Nevirapine—Urticaria—Fluorouracil—head and neck cancer	0.00061	0.00335	CcSEcCtD
Nevirapine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—head and neck cancer	0.000608	0.0138	CbGpPWpGaD
Nevirapine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000608	0.0138	CbGpPWpGaD
Nevirapine—Body temperature increased—Fluorouracil—head and neck cancer	0.000607	0.00334	CcSEcCtD
Nevirapine—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—head and neck cancer	0.000594	0.0135	CbGpPWpGaD
Nevirapine—Myalgia—Docetaxel—head and neck cancer	0.000578	0.00318	CcSEcCtD
Nevirapine—Arthralgia—Docetaxel—head and neck cancer	0.000578	0.00318	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000574	0.00315	CcSEcCtD
Nevirapine—CYP1A2—Estrogen Receptor Pathway—CYP1A1—head and neck cancer	0.000574	0.0131	CbGpPWpGaD
Nevirapine—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000574	0.0131	CbGpPWpGaD
Nevirapine—Hypersensitivity—Fluorouracil—head and neck cancer	0.000566	0.00311	CcSEcCtD
Nevirapine—Oedema—Docetaxel—head and neck cancer	0.000554	0.00305	CcSEcCtD
Nevirapine—Anaphylactic shock—Docetaxel—head and neck cancer	0.000554	0.00305	CcSEcCtD
Nevirapine—Nervous system disorder—Docetaxel—head and neck cancer	0.000544	0.00299	CcSEcCtD
Nevirapine—Pruritus—Fluorouracil—head and neck cancer	0.000543	0.00299	CcSEcCtD
Nevirapine—Thrombocytopenia—Docetaxel—head and neck cancer	0.000543	0.00298	CcSEcCtD
Nevirapine—Skin disorder—Docetaxel—head and neck cancer	0.000538	0.00296	CcSEcCtD
Nevirapine—Anorexia—Docetaxel—head and neck cancer	0.000528	0.0029	CcSEcCtD
Nevirapine—Diarrhoea—Fluorouracil—head and neck cancer	0.000525	0.00289	CcSEcCtD
Nevirapine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000519	0.0118	CbGpPWpGaD
Nevirapine—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000505	0.00277	CcSEcCtD
Nevirapine—Paraesthesia—Docetaxel—head and neck cancer	0.000498	0.00273	CcSEcCtD
Nevirapine—Somnolence—Docetaxel—head and neck cancer	0.000493	0.00271	CcSEcCtD
Nevirapine—Vomiting—Fluorouracil—head and neck cancer	0.000488	0.00268	CcSEcCtD
Nevirapine—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000486	0.0111	CbGpPWpGaD
Nevirapine—Rash—Fluorouracil—head and neck cancer	0.000484	0.00266	CcSEcCtD
Nevirapine—Dermatitis—Fluorouracil—head and neck cancer	0.000484	0.00266	CcSEcCtD
Nevirapine—Decreased appetite—Docetaxel—head and neck cancer	0.000482	0.00265	CcSEcCtD
Nevirapine—Headache—Fluorouracil—head and neck cancer	0.000481	0.00264	CcSEcCtD
Nevirapine—CYP2D6—Xenobiotics—CYP1A1—head and neck cancer	0.00048	0.0109	CbGpPWpGaD
Nevirapine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—head and neck cancer	0.000479	0.0109	CbGpPWpGaD
Nevirapine—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000479	0.00263	CcSEcCtD
Nevirapine—Fatigue—Docetaxel—head and neck cancer	0.000478	0.00263	CcSEcCtD
Nevirapine—CYP2C9—Xenobiotics—CYP1A1—head and neck cancer	0.000476	0.0108	CbGpPWpGaD
Nevirapine—Pain—Docetaxel—head and neck cancer	0.000474	0.0026	CcSEcCtD
Nevirapine—CYP1A2—Estrogen metabolism—GSTM1—head and neck cancer	0.000467	0.0106	CbGpPWpGaD
Nevirapine—CYP2D6—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000462	0.0105	CbGpPWpGaD
Nevirapine—CYP2C9—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000458	0.0104	CbGpPWpGaD
Nevirapine—Feeling abnormal—Docetaxel—head and neck cancer	0.000457	0.00251	CcSEcCtD
Nevirapine—Nausea—Fluorouracil—head and neck cancer	0.000456	0.00251	CcSEcCtD
Nevirapine—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000453	0.00249	CcSEcCtD
Nevirapine—CYP1A2—Estrogen metabolism—CYP1A1—head and neck cancer	0.000442	0.0101	CbGpPWpGaD
Nevirapine—Body temperature increased—Docetaxel—head and neck cancer	0.000438	0.00241	CcSEcCtD
Nevirapine—Abdominal pain—Docetaxel—head and neck cancer	0.000438	0.00241	CcSEcCtD
Nevirapine—Hypersensitivity—Docetaxel—head and neck cancer	0.000408	0.00224	CcSEcCtD
Nevirapine—CYP1A2—Xenobiotics—CYP1A1—head and neck cancer	0.000407	0.00925	CbGpPWpGaD
Nevirapine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000401	0.00912	CbGpPWpGaD
Nevirapine—Asthenia—Docetaxel—head and neck cancer	0.000398	0.00218	CcSEcCtD
Nevirapine—Pruritus—Docetaxel—head and neck cancer	0.000392	0.00215	CcSEcCtD
Nevirapine—CYP1A2—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000391	0.0089	CbGpPWpGaD
Nevirapine—Diarrhoea—Docetaxel—head and neck cancer	0.000379	0.00208	CcSEcCtD
Nevirapine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000375	0.00854	CbGpPWpGaD
Nevirapine—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.00036	0.0082	CbGpPWpGaD
Nevirapine—CYP2D6—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000357	0.00811	CbGpPWpGaD
Nevirapine—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000355	0.00809	CbGpPWpGaD
Nevirapine—Vomiting—Docetaxel—head and neck cancer	0.000352	0.00194	CcSEcCtD
Nevirapine—CYP2A6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000351	0.00798	CbGpPWpGaD
Nevirapine—Rash—Docetaxel—head and neck cancer	0.000349	0.00192	CcSEcCtD
Nevirapine—Dermatitis—Docetaxel—head and neck cancer	0.000349	0.00192	CcSEcCtD
Nevirapine—Headache—Docetaxel—head and neck cancer	0.000347	0.00191	CcSEcCtD
Nevirapine—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000341	0.00777	CbGpPWpGaD
Nevirapine—Nausea—Docetaxel—head and neck cancer	0.000329	0.00181	CcSEcCtD
Nevirapine—CYP2A6—Biological oxidations—NAT2—head and neck cancer	0.000327	0.00744	CbGpPWpGaD
Nevirapine—CYP2A6—NRF2 pathway—TGFA—head and neck cancer	0.000317	0.00721	CbGpPWpGaD
Nevirapine—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.000314	0.00714	CbGpPWpGaD
Nevirapine—CYP1A2—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000302	0.00687	CbGpPWpGaD
Nevirapine—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000302	0.00687	CbGpPWpGaD
Nevirapine—CYP2A6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000288	0.00656	CbGpPWpGaD
Nevirapine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000287	0.00653	CbGpPWpGaD
Nevirapine—CYP2B6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000283	0.00644	CbGpPWpGaD
Nevirapine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.00028	0.00638	CbGpPWpGaD
Nevirapine—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000277	0.00629	CbGpPWpGaD
Nevirapine—CYP1A2—Estrogen Receptor Pathway—STAT3—head and neck cancer	0.000266	0.00606	CbGpPWpGaD
Nevirapine—CYP1A2—Phase II conjugation—NAT2—head and neck cancer	0.000265	0.00604	CbGpPWpGaD
Nevirapine—CYP2B6—Biological oxidations—NAT2—head and neck cancer	0.000264	0.006	CbGpPWpGaD
Nevirapine—CYP2B6—Metapathway biotransformation—NAT2—head and neck cancer	0.00026	0.00592	CbGpPWpGaD
Nevirapine—CYP3A5—Biological oxidations—NAT2—head and neck cancer	0.000258	0.00587	CbGpPWpGaD
Nevirapine—CYP3A5—Metapathway biotransformation—NAT2—head and neck cancer	0.000254	0.00579	CbGpPWpGaD
Nevirapine—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000232	0.00529	CbGpPWpGaD
Nevirapine—CYP2C9—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000231	0.00526	CbGpPWpGaD
Nevirapine—CYP2C9—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000229	0.0052	CbGpPWpGaD
Nevirapine—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000227	0.00517	CbGpPWpGaD
Nevirapine—CYP1A2—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000209	0.00475	CbGpPWpGaD
Nevirapine—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	0.000209	0.00475	CbGpPWpGaD
Nevirapine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	0.000209	0.00475	CbGpPWpGaD
Nevirapine—CYP2A6—Fluoropyrimidine Activity—TP53—head and neck cancer	0.000203	0.00462	CbGpPWpGaD
Nevirapine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000199	0.00454	CbGpPWpGaD
Nevirapine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000198	0.0045	CbGpPWpGaD
Nevirapine—CYP1A2—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000197	0.00449	CbGpPWpGaD
Nevirapine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000197	0.00448	CbGpPWpGaD
Nevirapine—CYP1A2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000195	0.00445	CbGpPWpGaD
Nevirapine—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000195	0.00444	CbGpPWpGaD
Nevirapine—CYP2A6—NRF2 pathway—GSTM1—head and neck cancer	0.000184	0.00419	CbGpPWpGaD
Nevirapine—CYP2D6—Biological oxidations—NAT2—head and neck cancer	0.000183	0.00417	CbGpPWpGaD
Nevirapine—CYP2C9—Biological oxidations—NAT2—head and neck cancer	0.000182	0.00414	CbGpPWpGaD
Nevirapine—CYP2D6—Metapathway biotransformation—NAT2—head and neck cancer	0.000181	0.00411	CbGpPWpGaD
Nevirapine—CYP2C9—Metapathway biotransformation—NAT2—head and neck cancer	0.000179	0.00408	CbGpPWpGaD
Nevirapine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000169	0.00384	CbGpPWpGaD
Nevirapine—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000167	0.00379	CbGpPWpGaD
Nevirapine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000162	0.00368	CbGpPWpGaD
Nevirapine—CYP2A6—Biological oxidations—GSTM1—head and neck cancer	0.000161	0.00367	CbGpPWpGaD
Nevirapine—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000161	0.00367	CbGpPWpGaD
Nevirapine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.00016	0.00364	CbGpPWpGaD
Nevirapine—CYP1A2—Biological oxidations—NAT2—head and neck cancer	0.000155	0.00353	CbGpPWpGaD
Nevirapine—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	0.000153	0.00349	CbGpPWpGaD
Nevirapine—CYP2A6—Biological oxidations—CYP1A1—head and neck cancer	0.000153	0.00348	CbGpPWpGaD
Nevirapine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000137	0.00311	CbGpPWpGaD
Nevirapine—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000136	0.00309	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—UROD—head and neck cancer	0.000135	0.00306	CbGpPWpGaD
Nevirapine—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	0.000131	0.00298	CbGpPWpGaD
Nevirapine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.00013	0.00297	CbGpPWpGaD
Nevirapine—CYP2B6—Biological oxidations—GSTM1—head and neck cancer	0.00013	0.00296	CbGpPWpGaD
Nevirapine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000129	0.00293	CbGpPWpGaD
Nevirapine—CYP2B6—Metapathway biotransformation—GSTM1—head and neck cancer	0.000128	0.00292	CbGpPWpGaD
Nevirapine—CYP3A5—Biological oxidations—GSTM1—head and neck cancer	0.000127	0.0029	CbGpPWpGaD
Nevirapine—CYP3A5—Metapathway biotransformation—GSTM1—head and neck cancer	0.000126	0.00286	CbGpPWpGaD
Nevirapine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	0.000124	0.00283	CbGpPWpGaD
Nevirapine—CYP2B6—Biological oxidations—CYP1A1—head and neck cancer	0.000123	0.00281	CbGpPWpGaD
Nevirapine—CYP2B6—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000122	0.00277	CbGpPWpGaD
Nevirapine—CYP3A5—Biological oxidations—CYP1A1—head and neck cancer	0.000121	0.00275	CbGpPWpGaD
Nevirapine—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.00012	0.00273	CbGpPWpGaD
Nevirapine—CYP3A5—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000119	0.00271	CbGpPWpGaD
Nevirapine—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000118	0.00269	CbGpPWpGaD
Nevirapine—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000116	0.00264	CbGpPWpGaD
Nevirapine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	0.000115	0.00262	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—UROD—head and neck cancer	0.000109	0.00247	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—UROD—head and neck cancer	0.000106	0.00242	CbGpPWpGaD
Nevirapine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000106	0.0024	CbGpPWpGaD
Nevirapine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	9.78e-05	0.00223	CbGpPWpGaD
Nevirapine—CYP2D6—Biological oxidations—GSTM1—head and neck cancer	9.05e-05	0.00206	CbGpPWpGaD
Nevirapine—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	8.97e-05	0.00204	CbGpPWpGaD
Nevirapine—CYP2D6—Metapathway biotransformation—GSTM1—head and neck cancer	8.93e-05	0.00203	CbGpPWpGaD
Nevirapine—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	8.85e-05	0.00201	CbGpPWpGaD
Nevirapine—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	8.8e-05	0.002	CbGpPWpGaD
Nevirapine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	8.8e-05	0.002	CbGpPWpGaD
Nevirapine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	8.8e-05	0.002	CbGpPWpGaD
Nevirapine—CYP2D6—Biological oxidations—CYP1A1—head and neck cancer	8.58e-05	0.00195	CbGpPWpGaD
Nevirapine—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	8.51e-05	0.00194	CbGpPWpGaD
Nevirapine—CYP2D6—Metapathway biotransformation—CYP1A1—head and neck cancer	8.46e-05	0.00193	CbGpPWpGaD
Nevirapine—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	8.39e-05	0.00191	CbGpPWpGaD
Nevirapine—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	7.67e-05	0.00175	CbGpPWpGaD
Nevirapine—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	7.56e-05	0.00172	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—UROD—head and neck cancer	7.55e-05	0.00172	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—UROD—head and neck cancer	7.48e-05	0.0017	CbGpPWpGaD
Nevirapine—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	7.27e-05	0.00165	CbGpPWpGaD
Nevirapine—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	7.17e-05	0.00163	CbGpPWpGaD
Nevirapine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	7.07e-05	0.00161	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—UROD—head and neck cancer	6.39e-05	0.00146	CbGpPWpGaD
Nevirapine—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	5.92e-05	0.00135	CbGpPWpGaD
Nevirapine—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	5.84e-05	0.00133	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	5.81e-05	0.00132	CbGpPWpGaD
Nevirapine—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	5.61e-05	0.00128	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—NAT2—head and neck cancer	5.59e-05	0.00127	CbGpPWpGaD
Nevirapine—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	5.53e-05	0.00126	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	4.96e-05	0.00113	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—UROD—head and neck cancer	4.94e-05	0.00112	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—DPYD—head and neck cancer	4.9e-05	0.00112	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—YAP1—head and neck cancer	4.65e-05	0.00106	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—NAT2—head and neck cancer	4.51e-05	0.00103	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—NAT2—head and neck cancer	4.41e-05	0.001	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—DPYD—head and neck cancer	3.95e-05	0.0009	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—DPYD—head and neck cancer	3.87e-05	0.00088	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—YAP1—head and neck cancer	3.75e-05	0.000854	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—YAP1—head and neck cancer	3.67e-05	0.000835	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.3e-05	0.000751	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	3.27e-05	0.000743	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—NAT2—head and neck cancer	3.13e-05	0.000713	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—NAT2—head and neck cancer	3.11e-05	0.000707	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.82e-05	0.000642	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—TYMS—head and neck cancer	2.79e-05	0.000636	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.79e-05	0.000635	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—GSTM1—head and neck cancer	2.76e-05	0.000628	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—DPYD—head and neck cancer	2.75e-05	0.000626	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—DPYD—head and neck cancer	2.72e-05	0.00062	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—NAT2—head and neck cancer	2.66e-05	0.000604	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—GPX1—head and neck cancer	2.64e-05	0.000602	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—CYP1A1—head and neck cancer	2.62e-05	0.000596	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—YAP1—head and neck cancer	2.61e-05	0.000594	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—YAP1—head and neck cancer	2.59e-05	0.000588	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—DPYD—head and neck cancer	2.33e-05	0.00053	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—TYMS—head and neck cancer	2.25e-05	0.000513	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—GSTM1—head and neck cancer	2.23e-05	0.000507	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—YAP1—head and neck cancer	2.21e-05	0.000503	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—TYMS—head and neck cancer	2.2e-05	0.000501	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—GSTM1—head and neck cancer	2.18e-05	0.000495	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—GPX1—head and neck cancer	2.13e-05	0.000485	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CYP1A1—head and neck cancer	2.11e-05	0.000481	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—GPX1—head and neck cancer	2.08e-05	0.000474	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CYP1A1—head and neck cancer	2.06e-05	0.00047	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—NAT2—head and neck cancer	2.05e-05	0.000466	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.94e-05	0.000442	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—DPYD—head and neck cancer	1.8e-05	0.000409	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—YAP1—head and neck cancer	1.71e-05	0.000388	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.69e-05	0.000386	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.66e-05	0.000378	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—TYMS—head and neck cancer	1.57e-05	0.000356	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PTGS2—head and neck cancer	1.56e-05	0.000354	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—TYMS—head and neck cancer	1.55e-05	0.000353	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GSTM1—head and neck cancer	1.55e-05	0.000352	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GSTM1—head and neck cancer	1.53e-05	0.000349	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GPX1—head and neck cancer	1.48e-05	0.000337	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GPX1—head and neck cancer	1.47e-05	0.000334	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CYP1A1—head and neck cancer	1.47e-05	0.000334	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CYP1A1—head and neck cancer	1.45e-05	0.000331	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.45e-05	0.00033	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PTEN—head and neck cancer	1.36e-05	0.000309	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—TYMS—head and neck cancer	1.33e-05	0.000302	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GSTM1—head and neck cancer	1.31e-05	0.000298	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GPX1—head and neck cancer	1.26e-05	0.000286	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PTGS2—head and neck cancer	1.26e-05	0.000286	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CYP1A1—head and neck cancer	1.24e-05	0.000283	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PTGS2—head and neck cancer	1.23e-05	0.000279	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.2e-05	0.000272	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PTEN—head and neck cancer	1.1e-05	0.000249	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PTEN—head and neck cancer	1.07e-05	0.000244	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—TYMS—head and neck cancer	1.02e-05	0.000233	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.02e-05	0.000232	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.01e-05	0.00023	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GPX1—head and neck cancer	9.69e-06	0.000221	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CYP1A1—head and neck cancer	9.6e-06	0.000218	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PIK3CA—head and neck cancer	9.58e-06	0.000218	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PTGS2—head and neck cancer	8.73e-06	0.000199	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PTGS2—head and neck cancer	8.65e-06	0.000197	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—AKT1—head and neck cancer	7.82e-06	0.000178	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PIK3CA—head and neck cancer	7.73e-06	0.000176	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PTEN—head and neck cancer	7.61e-06	0.000173	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PIK3CA—head and neck cancer	7.55e-06	0.000172	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PTEN—head and neck cancer	7.55e-06	0.000172	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PTGS2—head and neck cancer	7.39e-06	0.000168	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PTEN—head and neck cancer	6.45e-06	0.000147	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—AKT1—head and neck cancer	6.31e-06	0.000144	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—AKT1—head and neck cancer	6.17e-06	0.00014	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PTGS2—head and neck cancer	5.71e-06	0.00013	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PIK3CA—head and neck cancer	5.37e-06	0.000122	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PIK3CA—head and neck cancer	5.32e-06	0.000121	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PTEN—head and neck cancer	4.98e-06	0.000113	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PIK3CA—head and neck cancer	4.55e-06	0.000104	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—AKT1—head and neck cancer	4.39e-06	9.98e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—AKT1—head and neck cancer	4.35e-06	9.9e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—AKT1—head and neck cancer	3.72e-06	8.46e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PIK3CA—head and neck cancer	3.51e-06	7.99e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—AKT1—head and neck cancer	2.87e-06	6.53e-05	CbGpPWpGaD
